The American Journal of Medicine
Volume 118, Issue 11 , Pages 1262-1270 , November 2005

Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population

  • Elham Rahme, PhD

      Affiliations

    • Department of Medicine, McGill University, Montreal, Canada
    • Research Institute, McGill University Health Center, Montreal, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • Dr. Rahme is a research scholar funded by The Arthritis Society.
    • Corresponding Author InformationRequests for reprints should be addressed to Elham Rahme, PhD, Division of Clinical Epidemiology, Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada.
    • ,
  • Denis Choquette, MD

      Affiliations

    • Rheumatology Institute and Centre Hospitalier de l’Université de Montréal – Notre-Dame, Montreal, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • ,
  • Michele Beaulieu, MEd

      Affiliations

    • Merck Frosst Canada Ltd., Montreal, Canada
    • Ms. Beaulieu is an employee at Merck Frosst Canada Ltd.
    • ,
  • Louis Bessette, MD, MSc

      Affiliations

    • Rimouski Regional Hospital, Rimouski, Canada
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.
    • ,
  • Lawrence Joseph, PhD

      Affiliations

    • Research Institute, McGill University Health Center, Montreal, Canada
    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    • ,
  • Youssef Toubouti, MSc

      Affiliations

    • Research Institute, McGill University Health Center, Montreal, Canada
    • ,
  • Jacques LeLorier, MD, PhD (FRCPC)

      Affiliations

    • Research Centre, Centre Hospitalier de l’Université de Montréal – Hôtel-Dieu, Montreal, Canada.
    • Drs. LeLorier, Choquette, Bessette and Rahme have served as consultants and paid speakers for Merck & Co. Inc. and for Pfizer Inc.

References 

  1. Morgan S . Drug spending in Canada (recent trends and causes) . Med Care. . 2004;42:635–642
  2. Bensen WG , Fiechtner JJ , McMillen JI , et al.   Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor (a randomized controlled trial) . Mayo Clin Proc. . 1999;74:1095–1105
  3. Goldstein JL , Silverstein FE , Agrawal NM , et al.   Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor . Am J Gastroenterol. . 2000;95:1681–1690
  4. Langman MJ , Jensen DM , Watson DJ , et al.   Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs . JAMA. . 1999;282:1929–1933
  5. Brooks P , Emery P , Evans JF , et al.   Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 . Rheumatology (Oxford) . 1999;38:779–788
  6. Bombardier C , Laine L , Reicin A , et al.  VIGOR Study Group   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis . N Engl J Med. . 2000;343:1520–1528
  7. Hawkey CJ , Laine L , Simon LS , et al.  The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group   Comparison of the effects of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen and placebo on gastroduodenal mucosa of patients with osteoarthritis (a randomized, placebo-controlled trial) . Arthritis Rheum.. . 2000;43:370–377
  8. Simon LS . Role and regulation of cyclooxygenase-2 during inflammation, position paper by expert panel on COX-1/COX-2 . Am J Med. . 1999;106:37S–42S
  9. Hochberg MC , Altman RD , Brandt KD , et al.  American College of Rheumatology   Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee . Arthritis Rheum. . 1995;38:1535–1546
  10. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines . Guidelines for the management of rheumatoid arthritis . Arthritis Rheum. . 1996;39:713–722
  11. Schnitzer TJ . Update of ACR guidelines for osteoarthritis (role of the coxibs) . J Pain Symptom Manage. . 2002;23:S24–S30
  12. American College of Rheumatology . Update of ACR guidelines for osteoarthritis (role of the coxibs) . J Pain Symptom Manage. . 2002;32(4 Suppl):S24–S30
  13. American College of Rheumatology . Update of ACR guidelines for osteoarthritis (role of the coxibs) . J Pain Symptom Manage. . 2002;32(4 Suppl):S31–S34
  14. Altman RD , Hochberg MC , Moskowitz RW , Schnitzer TJ . Recommendations for the medical management of osteoarthritis of the hip and knee (2000 update) . Arthritis Rheum. . 2000;43:1905–1915
  15. Pendleton A , Arden N , Dougados M , et al.   EULAR recommendations for the management of knee osteoarthritis (report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)) . Ann Rheum Dis. . 2000;59:936–944
  16. Chancellor JV , Hunsche E , de Cruz E , Sarasin FP . Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland . Pharmacoeconomics. . 2001;19:59–75
  17. Pellissier JM , Straus WL , Watson DJ , Kong SX , Harper SE . Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis . Clin Ther. . 2001;23:1061–1079
  18. Haglund U , Svarvar P . The Swedish ACCES model (predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis) . Rheumatology (Oxford). . 2000;39:51–56
  19. Cox-2 agents’ impact on NSAID and GI drug use and cost (What’s been seen in practice?) . Formulary. . 2000;35:71–75
  20. Davis D , O’Brien MAT , Freemantle N , Wolf FM , Mazmanian P , Taylor-Vaisey A . Impact of formal continuing medical education (do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?) . JAMA. . 1999;282:867–874
  21. Mazmanian PE , Davis DA . Continuing medical education and the physician as a learner (guide to the evidence) . JAMA. . 2002;288:1057–1060
  22. Hayward RSA , Guyatt GH , Moore KA , McKibbon A , Carter AO . Canadian physicians’ attitudes about and preferences regarding clinical practice guidelines . CMAJ. . 1997;156:1715–1723
  23. Ioannou GN , Spector J , Scott K , Rockey DC . Prospective evaluation of a clinical guideline for the diagnosis and management of iron deficiency anemia . Am J Med. . 2002;113:281–287
  24. Rahme E , Marentette MA , Kong SX , LeLorier J . Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated co-prescriptions of gastroprotective agents in an elderly population . Arthritis Care Res. . 2002;47:595–602
  25. Labelle M , Beaulieu M , Paquette D , et al.   An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Quebec (the CURATA model) . Med Teach. . 2004;26:463–470
  26. Charlin B , Roy L , Brailovsky C , Goulet F , van der Vleuten C . The Script Concordance test (a tool to assess the reflective clinician) . Teach Learn Med. . 2000;12:189–195
  27. Beaulieu M , Choquette D , Rahme E , Bessette L , Carrier R . CURATA: a patient health management program for the treatment of osteoarthritis in Quebec: an integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications . Am J Manag Care. . 2004;10:569–575
  28. Wilchesky M , Tamblyn RM , Huang A . Validation of diagnostic codes within medical services claims . J Clin Epidemiol. . 2004;57:131–141
  29. Figueiras A , Sastre I , Tato F , et al.   One-to-one versus group sessions to improve prescription in primary care (a pragmatic randomized controlled trial) . Med Care. . 2001;39:158
  30. Gerstein HC , Reddy SSK , Dawson KG , Yale JF , Shannon S , Norman G . A controlled evaluation of a national continuing medical education programme designed to improve family physicians’ implementation of diabetes-specific clinical practice guidelines . Diabet Med. . 1999;16:964–969
  31. Figueiras A , Sastre I , Gestal-Otero JJ . Effectiveness of educational interventions on the improvement of drug prescription in primary care (a critical literature review) . J Eval Clin Pract. . 2001;7:223–241

PII: S0002-9343(05)00245-7

doi: 10.1016/j.amjmed.2005.03.026

The American Journal of Medicine
Volume 118, Issue 11 , Pages 1262-1270 , November 2005

Article Tools

* Image Usage & Resolution